- Home
- CRVS vs MYD Comparison
CRVS vs MYD Comparison
Compare CRVS & MYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- MYD
- Stock Information
- Founded
- CRVS 2014
- MYD 1991
- Country
- CRVS United States
- MYD United States
- Employees
- CRVS N/A
- MYD N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- MYD Investment Bankers/Brokers/Service
- Sector
- CRVS Health Care
- MYD Finance
- Exchange
- CRVS Nasdaq
- MYD Nasdaq
- Market Cap
- CRVS 459.0M
- MYD 460.1M
- IPO Year
- CRVS 2016
- MYD N/A
- Fundamental
- Price
- CRVS $5.79
- MYD $10.66
- Analyst Decision
- CRVS Strong Buy
- MYD
- Analyst Count
- CRVS 4
- MYD 0
- Target Price
- CRVS $15.00
- MYD N/A
- AVG Volume (30 Days)
- CRVS 547.2K
- MYD 253.1K
- Earning Date
- CRVS 11-11-2025
- MYD 01-01-0001
- Dividend Yield
- CRVS N/A
- MYD 4.55%
- EPS Growth
- CRVS N/A
- MYD N/A
- EPS
- CRVS N/A
- MYD N/A
- Revenue
- CRVS N/A
- MYD N/A
- Revenue This Year
- CRVS N/A
- MYD N/A
- Revenue Next Year
- CRVS N/A
- MYD N/A
- P/E Ratio
- CRVS N/A
- MYD N/A
- Revenue Growth
- CRVS N/A
- MYD N/A
- 52 Week Low
- CRVS $2.54
- MYD $8.76
- 52 Week High
- CRVS $10.00
- MYD $11.30
- Technical
- Relative Strength Index (RSI)
- CRVS 56.88
- MYD 79.24
- Support Level
- CRVS $5.64
- MYD $9.91
- Resistance Level
- CRVS $6.09
- MYD $10.06
- Average True Range (ATR)
- CRVS 0.34
- MYD 0.09
- MACD
- CRVS -0.05
- MYD 0.05
- Stochastic Oscillator
- CRVS 50.00
- MYD 95.95
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About MYD Blackrock MuniYield Fund Inc.
Blackrock Muniyield Fund Inc is a non-diversified, closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.